ALLK
Price
$1.35
Change
+$0.10 (+8.00%)
Updated
Nov 5, 04:50 PM (EDT)
6 days until earnings call
GNPX
Price
$1.81
Change
-$0.21 (-10.40%)
Updated
Nov 5, 04:00 PM (EDT)
Ad is loading...

ALLK vs GNPX

Header iconALLK vs GNPX Comparison
Open Charts ALLK vs GNPXBanner chart's image
Allakos
Price$1.35
Change+$0.10 (+8.00%)
Volume$11.62K
CapitalizationN/A
Genprex
Price$1.81
Change-$0.21 (-10.40%)
Volume$111.27K
CapitalizationN/A
View a ticker or compare two or three
ALLK vs GNPX Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLK vs. GNPX commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a StrongBuy and GNPX is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (ALLK: $1.25 vs. GNPX: $2.02)
Brand notoriety: ALLK and GNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 84% vs. GNPX: 7%
Market capitalization -- ALLK: $111.06M vs. GNPX: $5.23M
ALLK [@Biotechnology] is valued at $111.06M. GNPX’s [@Biotechnology] market capitalization is $5.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileGNPX’s FA Score has 1 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • GNPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALLK and GNPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 5 TA indicator(s) are bullish while GNPX’s TA Score has 4 bullish TA indicator(s).

  • ALLK’s TA Score: 5 bullish, 4 bearish.
  • GNPX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALLK is a better buy in the short-term than GNPX.

Price Growth

ALLK (@Biotechnology) experienced а -3.10% price change this week, while GNPX (@Biotechnology) price change was -26.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

ALLK is expected to report earnings on Mar 04, 2025.

GNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLK($111M) has a higher market cap than GNPX($5.23M). ALLK YTD gains are higher at: -54.212 vs. GNPX (-78.043). GNPX has higher annual earnings (EBITDA): -26.28M vs. ALLK (-182.51M). ALLK has more cash in the bank: 123M vs. GNPX (2.46M). GNPX has less debt than ALLK: GNPX (279K) vs ALLK (39.7M). ALLK (0) and GNPX (0) have equivalent revenues.
ALLKGNPXALLK / GNPX
Capitalization111M5.23M2,123%
EBITDA-182.51M-26.28M695%
Gain YTD-54.212-78.04369%
P/E RatioN/AN/A-
Revenue00-
Total Cash123M2.46M5,002%
Total Debt39.7M279K14,229%
FUNDAMENTALS RATINGS
ALLK vs GNPX: Fundamental Ratings
ALLK
GNPX
OUTLOOK RATING
1..100
2129
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3634
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNPX's Valuation (21) in the Pharmaceuticals Major industry is in the same range as ALLK (22). This means that GNPX’s stock grew similarly to ALLK’s over the last 12 months.

GNPX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ALLK (100). This means that GNPX’s stock grew similarly to ALLK’s over the last 12 months.

ALLK's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as GNPX (99). This means that ALLK’s stock grew similarly to GNPX’s over the last 12 months.

GNPX's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as ALLK (36). This means that GNPX’s stock grew similarly to ALLK’s over the last 12 months.

GNPX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as ALLK (100). This means that GNPX’s stock grew similarly to ALLK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLKGNPX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBWI31.282.36
+8.16%
Bath & Body Works
NNDM2.210.03
+1.61%
Nano Dimension Ltd
MVO8.850.03
+0.34%
MV Oil Trust
BNRG0.84-0.02
-2.33%
Brenmiller Energy Ltd
SRRK27.67-0.75
-2.64%
Scholar Rock Holding Corp

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
-1.57%
AXON - ALLK
38%
Loosely correlated
+1.35%
PRME - ALLK
38%
Loosely correlated
-1.49%
ENSC - ALLK
36%
Loosely correlated
-12.60%
GNPX - ALLK
34%
Loosely correlated
-6.05%
AKBA - ALLK
34%
Loosely correlated
+9.17%
More

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-6.05%
REVB - GNPX
48%
Loosely correlated
+3.25%
HOWL - GNPX
37%
Loosely correlated
-8.67%
ALLK - GNPX
34%
Loosely correlated
-1.57%
GRI - GNPX
34%
Loosely correlated
-5.45%
ENSC - GNPX
33%
Poorly correlated
-12.60%
More